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The Gut Tactical-Response Unit
How an immune response to pathogens is initiated in
the gut is still an open question. In this issue of Immu-
nity, Salazar-Gonzales et al., 2006 find that a distinct
subset of CCR6-expressing dendritic cells are abso-
lutely required to activate anti-Salmonella-specific
T cells.
Salmonella typhimurium is an oral pathogenic bacte-
rium that has exploited M cells in the intestine to gain
access across mucosal surfaces (Jepson and Clark,
2001). M cells are specialized epithelial cells that are
localized in the follicle-associated epithelium (FAE) of
Peyer’s Patches (PP). M cells lack an organized brush
border and invasive bacteria, such as Salmonella, that
are equipped with a type-three secretion system can
easily contact the plasma membrane to induce their
own phagocytosis. Salmonella has been shown to enter
in the PP and to colocalize with dendritic cells (DCs) in
the subepithelial dome (SED) (Hopkins and Kraehen-
buhl, 1997). At least three different subsets of DCs have
been described in PP (Iwasaki and Kelsall, 2000). All of
them express the DC-specific cell marker CD11c and
different amounts of CCR7 but are distinguishable for
the expression of the CD11b, CD8a, and CCR6 surface
markers. These three cell types have specialized func-
tion; the myeloid type (CD11b+CD8a2CCR6+) activates
primarily T helper (Th)-2 T cells that produce IL-10, the
CD11b2CD8a+CCR62 DCs are localized in the T cell in-
terfollicular area (IFR) and activate Th1-type responses,
and the CD11b2CD8a2CCR6+ DCs are located both in
the SED and in the IFR and can also activate Th1-type
of responses (Iwasaki and Kelsall, 2001).
A second mechanism for bacterial uptake is mediated
by dendritic cells that express tight-junction proteins
and extend dendrites between epithelial cells for direct
bacterial uptake (Rescigno et al., 2001). The extension
of these processes relies on the expression of CX3CR1,
the receptor of fractalkine (Niess et al., 2005). Mice de-
ficient for CX3CR1 lack DC protrusions across epithelial
barriers and are more susceptible to Salmonella infec-
tion, suggesting that CX3CR1
+ cells are important in
the defense against these bacteria (Niess et al., 2005).
Given the important role of DCs in the initiation of adap-
tive immune responses, several important issues arise.
Are DCs required to initiate anti-Salmonella-specific T
cell responses? What is the function of DCs located in
the SED as compared to those that take up bacteria
directly from the intestinal lumen? Are these different
subsets specialized in particular functions?
McSorley and colleagues have started to answer
these questions (Salazar-Gonzales et al., 2006). They
analyzed the role of DCs, and in particular of CCR6+
DCs, in the initiation of a T cell response to Salmonella
by using two very elegant systems. In the first, they
used a diphteria toxin DC-depletion system. In thesecond, they used mouse strains with deletion or green
fluorescent protein (GFP) insertion in the gene coding
for CCR6 (the receptor for the chemokine CCL20). In
both cases, they followed the activation of adoptively
transferred T cells from a S. typhimurium flagellin-
specific TCR transgenic mouse. They found that DCs
are absolutely required to initiate anti-Salmonella-
specific T cell responses (Figure 1). In fact, in mice lack-
ing DCs, anti-Salmonella T cells could not be activated.
Because CCR6+ DCs have been shown to populate the
SED of PP, the authors focused their attention on this
cell type. In contrast to what has been generally
thought, i.e., that CCR6+ cells migrate out of the SED
after bacterial infection, Salazar-Gonzales et al. showed
that CCR6+ cells are rapidly recruited within the FAE
a few hours after oral Salmonella infection. These cells
are different from the CX3CR1+ cells that do not express
CCR6 and are located in close proximity to M cells. The
recruitment of CCR6+ DCs is absolutely dependent on
CCR6 expression; these cells are not recruited to the
FAE in CCR6-deficient mice. However, this recruitment
is unlikely to be dependent on CCL20 because it is con-
stitutively expressed by the FAE and CCR6+ cells
should be attracted to the FAE independently of bacte-
rial infection.
CCR6+ cells are necessary for a rapid T cell activation
and soon after bacterial infection are found in close con-
tact with anti-Salmonella-specific T cells. Thus, even
though CX3CR1
+ cells are ideally located to take up Sal-
monella and to initiate an adaptive immune response,
this task seems to be carried out by CCR6+ cells that
have to be recruited to the FAE. Although this seems
to be a paradox, it could denote a defense mechanism
to avoid exaggerated inflammatory responses in the
gut. CX3CR1
+ cells could represent a type of general
‘‘scanner’’ of the intestinal lumen; such scanners could
allow sampling and presentation of non-dangerous
commensal bacteria. This is consistent with a recent
finding showing that epithelial cells play a major role in
driving non-inflammatory DCs through the release of
soluble mediators including the thymic stromal lym-
phopoietin (TSLP) (Rimoldi et al., 2005). Therefore, the
intraepithelial CX3CR1
+ DCs could be ‘‘conditioned’’
by epithelial-cell-derived factors to carry out non-
inflammatory responses. In order to initiate protective
immunity, a pool of fully competent DCs able to respond
quickly and properly to bacteria is required. These cells
could be represented by the CCR6+ DCs that have been
kept at a distance to avoid their conditioning by epithe-
lial cells but close enough to be rapidly recruited should
an infection occur. A similar scenario has been de-
scribed in the skin and buccal mucosa, where rapid re-
cruitment of CCR6+ cells has been shown to be required
for CD8+ T cell cross-priming (Le Borgne et al., 2006).
Besides CCL20, at least one other chemokine (CCL9)
has been shown to play a role in the recruitment of
CD11b+ DCs in the SED. When treated with neutralizing
antibodies to CCL9, mice lacking CCR6 display much-
reduced CD11b+ DCs within the SED (Zhao et al.,
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509Figure 1. Peyer’s Patches CCR6+ and CX3CR1+ CD11c+ DCs Are Functionally Distinct DC Subsets
During the unperturbed or ‘‘steady-state’’ condition (left), CX3CR1+ DCs sample the intestinal luminal content either directly by extending den-
drites from the lamina propria (LP) across the epithelial barrier or indirectly after antigen transcytosis across M cells in the follicle-associated
epithelium (FAE) of Peyer’s Patches (PP). CCR6+ DCs are just below the subepithelial dome of PP and cannot be found in the LP of intestinal
villi. After Salmonella infection (right), although CX3CR1
+ DCs are induced to extend their dendrites across epithelial cells in LP, CCR6+ DCs
are recruited to the FAE in PP, but not in LP. CCR6+ DCs are required for rapid T cell activation. In the FAE, clusters of CCR6+ DCs with Salmo-
nella-specific T cells could be found, whether this contributes to T cell activation or whether CCR6+ DCs need to migrate to the interfollicular T
cell region remains to be established. The identity of CCR6+ DCs in terms of surface marker expression (CCR7, CD11b, CD8a) remains unclear.2003). As mentioned above, CCR6 is expressed on
two DC subtypes, the CD11b+ and the CD11b2 popula-
tions, in the PP. These two cell types are functionally dif-
ferent because the CD11b+ cells drive the development
of Th2 type of T cells, whereas the CD11b2 population
drives Th1 type of responses, which are required for
efficient clearance of Salmonella. Of these two pop-
ulations, only the CCR6+CD11b+ cells are responsive
to CCL9 and might therefore also populate the SED
in the absence of CCR6 expression, whereas the
CD11b2 population is not responsive to CCL9 and could
be missing in the CCR6-deficient mice (Zhao et al.,
2003). It would be interesting to know the contribution of
each cell type in the induction of T cell responses to bac-
teria. Another important issue that needs to be answered
is the chemokine orcytokine axis (or both) thatdetermines
the location of CCR6+ DCs. How are these cells kept
away from the FAE if they express CCR6 and can respond
to CCL20 that is constitutively released by FAE? How are
these cells recruited in the FAE? What is the role of CCL9?
Because the authors showedthat CCR6+ cells are found in
cluster with anti-Salmonella-specific T cells in the SED, it
would be interesting to know whether T cell activation
can take place in this location or whether DCs have to mi-
grate into the IFR. Salazar-Gonzales et al. could detect
CCR6+ cells in the IFR; this is not surprising because it
has been previously shown that CCR6+ cells can also ex-
pressCCR7and canmigrate towardCCL21 within the IFR,
but whether these cells are migratory from the SED re-
mains to be established. Salazar-Gonzales et al. showthat the kinetic of T cell activation in the PP is always faster
than that in the mesenteric lymph nodes (MLN), even
though at later time points the expansion of anti-Salmo-
nella T cells is very similar at both sites. It is unclear
whether T cells that are activated in the PP migrate into
the MLN or whether T cells are also activated in
the MLN, perhaps by DCs that are migrating from the
PP or from the lamina propria of intestinal villi. According
to Salazar-Gonzales et al., the latter possibility is unlikely
because they could not detect recruitment of CCR6+
DCs in the LP and they have shown that these cells are re-
quired for T cell activation. Finally, Salazar-Gonzales et al.
show that the reduced T cell activation correlates with in-
creased numbers of bacteria in the liver and the spleen of
CCR6-deficient mice, suggesting that activated T cells are
required to control bacterial growth.
Initiation of an immune response in the gut should be
viewed as a very complex and coordinated event that
requires the interaction of immune and environmental
cells, and in particular of epithelial cells. It seems the
latter decipher the messages released by luminal bacte-
ria and make decisions to call the CCR6+ DCs tactical-
response unit into action.
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Parallel Pathways
of Virus Recognition
Viruses trigger signaling pathways of innate immu-
nity. In this issue, Sun et al. (2006) show that the mito-
chondrial antiviral signaling protein is critical for intra-
cellular detection signaling, but is dispensable for the
activation of innate immunity via Toll-like receptors.
Our understanding of the molecular machinery required
for the recognition of virus infection has been shaped
by the discovery of two complementary pathways medi-
ated by pattern-recognition receptors (Kawai and Akira,
2006). Extracellular viral components bind to transmem-
brane-anchored, endosomal members of the Toll-like re-
ceptor (TLR) family and transduce a signal via cytoplas-
mic adaptor proteins. In the other pathway, cytoplasmic
receptors such as the retinoic-acid-inducible gene I
(RIG-I) mediate the induction of response genes from in-
tracellular pathogen-produced substrates (Kawai and
Akira, 2006). After the engagement of these specialized
receptors, adaptor proteins assemble to form multisub-
unit complexes that activate kinases such as the ca-
nonical IKK complex, the IKK-related kinases (TBK1
and IKK3), and IRAK1-IKKa. These kinases then phos-
phorylate downstream targets (inhibitors or activators),
leading to the activation of NF-kB and IRF family mem-
bers of transcription factors (Hoshino et al., 2006; Kawai
and Akira, 2006). The end result of these signaling path-
ways is the assembly of an enhanceosome, the tran-
scription enhancer complex that drives expression of
the interferon beta (IFN-b) gene (Maniatis et al., 1998)
(Figure 1).
IFN-b is a pleiotropic cytokine that orchestrates the
coordination of innate and adaptive immunity in re-
sponse to virus infection. The discovery of the mito-
chondrial antiviral signaling (MAVS) protein provided a
missing component linking TLR- and RIG-I-dependent
signaling events to the downstream kinases responsible
for enhanceosome assembly. MAVS was simultaneously
discovered by four independent groups and is alsoRescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G.,
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referred to as the IFN-b promoter stimulator 1 (IPS-1),
CARD adaptor inducing IFN-b (Cardif), and virus-
induced signaling adaptor (VISA) (Kawai and Akira,
2006; Kawai et al., 2005; Seth et al., 2005; Xu et al.,
2005). These studies revealed interactions between
MAVS and a number of components involved in both
the intracellular and extracellular detection machinery,
suggesting that signaling from all pattern-recognition re-
ceptors converges on this mitochondrial adaptor.
Now, a decisive study in this issue of Immunity (Sun
et al., 2006) confirms the critical role of MAVS in mediat-
ing RIG-I-dependent signaling, but reveals that MAVS
does not serve as a downstream target of RIG-I-inde-
pendent pathogen recognition. Through the generation
of Mavs2/2 mice, Sun et al. investigated the ex vivo role
of MAVS in response to infection by both virus (Sendai
virus and double-stranded RNA [dsRNA]) and bacteria
(lipopolysaccharide [LPS], cytoplasmic DNA, and Liste-
ria monocytogenes). In the case of virus infection, they
find that MAVS is required for IFN-b production in all cell
types examined, except plasmocytoid dendritic cells
(pDCs). In contrast, MAVS is not required for IFN-b pro-
duction in response to extracellular dsRNA through
TLR3, to LPS through TLR4, to treatment with cytoplas-
mic DNA, or in response to infection by Listeria monocy-
togenes. This was true for all cell types examined. These
findings, contrary to initial reports (Xu et al., 2005), con-
clusively demonstrate that MAVS is a unique adaptor of
the RIG-I pathway.
Studies were also carried out to investigate the role of
MAVS in the antiviral response in vivo. Wild-type and
Mavs2/2mice were infected with Vesicular Stomatitis Vi-
rus (VSV), and the amounts of IFN-b were determined.
Despite the lack of IFN-b production ex vivo in virus-
infected Mavs2/2 embryonic fibroblasts (MEFs), bone-
marrow-derived macrophages (BMDM), peritoneal mac-
rophages, or conventional dendritic cells (cDC), normal
amounts of IFN-b were observed in Mavs2/2 mice
infected with VSV. This observation is perhaps not
surprising, because pDCs, which respond normally to
virus infection in the absence of MAVS ex vivo, are the
primary source of IFN in response to VSV in vivo (Barchet
et al., 2002). Despite the normal amounts of IFN-b in
